Contrast Harmonic Sonography-Guided Radiofrequency Ablation Therapy Versus B-Mode Sonography in Hepatocellular Carcinoma: Prospective Randomized Controlled Trial-Reference-Cited by-同舟云学术

Contrast Harmonic Sonography-Guided Radiofrequency Ablation Therapy Versus B-Mode Sonography in Hepatocellular Carcinoma: Prospective Randomized Controlled Trial

Published:2007-02 Issue:2 Volume:188 Page:489-494
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Minami Yasunori,Kudo Masatoshi,Chung Hobyung,Kawasaki Toshihiko,Yagyu Yukinobu,Shimono Taro,Shiozaki Hitoshi

Publisher

American Roentgen Ray Society

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference29 articles.

1. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma.Cancer J Sci Am1995; 1:73-81

2. Local ablation therapy for hepatocellular carcinoma: current status and future perspectives

3. Locoregional Therapies for Hepatocellular Carcinoma: A Critical Review From the Surgeon’s Perspective

4. Hepatocellular Carcinoma: Radio-frequency Ablation of Medium and Large Lesions

5. Percutaneous Sonographically Guided Saline-Enhanced Radiofrequency Ablation of Hepatocellular Carcinoma

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tips for Preparing and Practicing Thermal Ablation Therapy of Hepatocellular Carcinoma;Cancers;2023-09-28

2. Contrast-Enhanced Ultrasound for Image-Guided Procedures;Techniques in Vascular and Interventional Radiology;2023-09

3. Contrast-Enhanced Ultrasonography and Its Application in Liver Interventions;Hong Kong Journal of Radiology;2023-03-24

4. Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy;Liver Cancer;2023

5. Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study;Liver Cancer;2023